Drug Reactions Sampling (COLLECTIONTOXIDERMIES)

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 5, 2018

Keywords

ClinConnect Summary

The clinical trial, called COLLECTIONTOXIDERMIES, is being conducted at the dermatology department of Henri Mondor Hospital in France. This study aims to collect important health information and biological samples from patients who are experiencing severe skin reactions caused by medications. These conditions include Stevens-Johnson Syndrome, Lyell Syndrome, and other serious drug-related skin issues. The goal is to better understand how these drug reactions happen, which could lead to improved treatments in the future.

To participate in this trial, individuals must be at least 18 years old and have a severe skin reaction related to medication. Participants will need to provide signed consent and have social security coverage. If eligible, they can expect to provide a small skin sample, blood, and other tissue samples for research. The collected samples will be carefully stored for future studies that aim to uncover the underlying causes of these serious skin reactions. This research is crucial for developing better prevention and treatment strategies for patients affected by drug reactions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient ≥ 18 y-old
• • Severe cutaneous drug reaction (AGEP, DRESS, SJS/TEN, generalized bullous fixed drug eruption), drug-induced IgA bullous dermatosis, maculopapular exanthema, erythema multiforme
• • Signed consent
• • Social security affiliation
• Exclusion Criteria:
• • Patients law protection